Altasciences Bet the Drug Lab on One Idea: Fewer Handoffs, Faster Answers

The Montreal-area CRO escaped the commodity economics of generic-drug testing by stitching labs, clinics and manufacturing into one early-development platform. Its wager is simple: the science need not move recklessly for the program to move faster.